Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04993638 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Post Market Clinical Follow-up of Dual-mobility Acetabular Cup EUROSCUP MOBILE

StatusActive, Not Recruiting
PhaseNot specified
SponsorEUROS
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Primary completion date: Jun 1, 2024 to Jun 1, 2034
    • Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 4 to 3
    • Study completion date: Jun 1, 2034 to Jun 2034
    v4
  2. Minor 2 versions Re-verified since Feb 13, 2023, no change to tracked fieldsv2-v3
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
4 trials monitored
See all monitored trials
EUROSCUP MOBILE is intended for use in primary and revision total hip replacement surgery. Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. As part of post market vigilance, EUROS will collect data on EUROSCUP MOBILE performances and safety
Trial Details
NCT Number NCT04993638
Lead Sponsor EUROS
Conditions
(from sponsor)
Hip Arthropathy, Hip Osteoarthritis, Hip Arthritis, Hip Fractures, Hip Necrosis, Hip Dysplasia
Related terms Hip Dislocation, Hip Fractures, Osteoarthritis, Hip
Enrollment 147 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov